Quest Diagnostics (DGX) is trading slightly higher this session, up 13 cents to $49.27 as I write. I want to use this bump to close out the position.
After you read this Alert, I'll sell my final 1,100 shares. Even though I believe this stock is very cheap, there are too many issues facing the company right now and I just don't see much upside over the next few months. I want to put this capital to work in other situations where I see a more immediate reward.
In other news, Clorox (CLX) is ramping on buyout rumors, trading up $1.71 to $67.46 as I write this. The company just recently brought in a new CEO so I doubt the entire entity is for sale, but I wouldn't be surprised if it announced the divestiture of some non-core brands at its May 24 analyst day.
Regards,
Jim Cramer
DISCLOSURE: At the time of publication, Cramer was long Quest Diagnostics and Clorox.
Send email to james.cramer@thestreet.com.